Intuitive Surgical (NASDAQ:ISRG) EVP Gary Loeb Sells 400 Shares of Company Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG) EVP Gary Loeb sold 400 shares of the business’s stock in a transaction dated Tuesday, November 10th. The shares were sold at an average price of $458.15, for a total value of $183,260.00. Following the completion of the transaction, the executive vice president directly owned 6,236 shares of the company’s stock, valued at approximately $2,857,023.40. This trade represents a 6.03% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Intuitive Surgical Stock Down 2.1%

ISRG opened at $439.89 on Friday. Intuitive Surgical, Inc. has a twelve month low of $328.57 and a twelve month high of $603.88. The company has a 50-day simple moving average of $416.12 and a 200 day simple moving average of $430.38. The stock has a market capitalization of $152.48 billion, a price-to-earnings ratio of 53.19, a P/E/G ratio of 3.10 and a beta of 1.45.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Tuesday, October 20th. The medical equipment provider reported $3.00 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.65 by $0.35. Intuitive Surgical had a net margin of 25.54% and a return on equity of 18.17%. The firm had revenue of $3.05 billion for the quarter, compared to the consensus estimate of $2.91 billion. During the same period in the prior year, the company posted $2.40 earnings per share. The business’s revenue for the quarter was up 21.7% on a year-over-year basis. Sell-side analysts anticipate that Intuitive Surgical, Inc. will post 9.37 EPS for the current fiscal year.

Institutional Investors Weigh In On Intuitive Surgical

Several hedge funds have recently modified their holdings of the company. Bank of America Corp DE increased its holdings in Intuitive Surgical by 3.3% in the 1st quarter. Bank of America Corp DE now owns 3,616,973 shares of the medical equipment provider’s stock worth $1,667,388,000 after purchasing an additional 116,292 shares in the last quarter. Bank of New York Mellon Corp bought a new position in Intuitive Surgical in the second quarter valued at about $1,335,753,000. Amundi raised its position in Intuitive Surgical by 8.6% in the first quarter. Amundi now owns 2,428,356 shares of the medical equipment provider’s stock valued at $1,119,448,000 after purchasing an additional 193,096 shares during the last quarter. Arrowstreet Capital Limited Partnership boosted its stake in shares of Intuitive Surgical by 95.3% during the first quarter. Arrowstreet Capital Limited Partnership now owns 2,105,544 shares of the medical equipment provider’s stock valued at $970,635,000 after purchasing an additional 1,027,475 shares in the last quarter. Finally, Sumitomo Mitsui Trust Group Inc. boosted its stake in shares of Intuitive Surgical by 10.8% during the third quarter. Sumitomo Mitsui Trust Group Inc. now owns 1,893,485 shares of the medical equipment provider’s stock valued at $769,948,000 after purchasing an additional 184,044 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages have recently weighed in on ISRG. Raymond James Financial reaffirmed an “outperform” rating and set a $480.00 price target on shares of Intuitive Surgical in a report on Wednesday, October 21st. Zacks Research raised shares of Intuitive Surgical from a “hold” rating to a “strong-buy” rating in a research note on Thursday, October 22nd. Truist Financial decreased their price objective on shares of Intuitive Surgical from $580.00 to $510.00 and set a “buy” rating on the stock in a research note on Thursday, July 16th. Citigroup lowered their price objective on shares of Intuitive Surgical from $590.00 to $500.00 and set a “buy” rating for the company in a research report on Friday, July 17th. Finally, KeyCorp restated an “overweight” rating on shares of Intuitive Surgical in a research note on Wednesday, August 12th. One investment analyst has rated the stock with a Strong Buy rating, twenty-three have issued a Buy rating, five have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and an average price target of $493.54.

Intuitive Surgical Company Profile

Intuitive Surgical develops, manufactures and markets robotic-assisted systems for minimally invasive procedures. Its products include da Vinci surgical systems, which allow surgeons to control instruments and a high-definition vision system from a console, as well as the Ion endoluminal system, designed to assist with minimally invasive lung biopsies. The company also provides instruments, accessories, training and support services for its systems. Its technology is used in a range of surgical specialties, including urology, general surgery and gynecology.